| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | A |
| 3. Samples | A |
| 4. Measurand | A |
| 5. Pre-Analytical | C |
| 6. Replicate Analysis | B |
| 7. Steady State | C |
| 8. Outlier Analysis | C |
| 9. Normality | B |
| 10. Variance Homogeneity | C |
| 11. ANOVA | C |
| 12. CI | A |
| 13. No of Results | C |
| 14. Concentrations | A |
| 15. Total Score | C5,7,8,10,11,13 |
| Comment |
| Parameter | Score |
|---|---|
| Matrix | Serum |
| Measurand | Parathyroid hormone |
| Unit | pg / mL |
| Overall Analytical Principle Method | Immunoassay; Non-competitive |
| Number of Subjects | 160 |
| Number of Subjects included in BV estimation | 160 |
| Ethinicity | Mixed |
| Age Mean / Median | 76.0 |
| Age Min | 68.0 |
| Age Max | 88.0 |
| Age SD | |
| Number of Males | 64 |
| Number of Females | 96 |
| State of Well Being |
Non-healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 6 |
| Study Duration Units | Week |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | 1 |
| Interval Units | Other |
| Sampling Times | Start Time:
End Time: |
| Number of Samples | 2 |
| Average Number of Samples Used for BV Estimation | 2.0 |
| Average Number of Replicates | |
| Estimates of CVi | 16.7 |
| Calculated Confidence Intervals of CVi | Lower: 14.84, Upper: 18.93 |
| Estimates of CVg | 37.9 |
| Calculated Confidence Intervals of CVg | Lower: 33.71, Upper: 43.03 |
| Analytical CV | 5.1 |
| Calculated Confidence Intervals of Analytical CV | Lower: 4.10, Upper: 6.75 |
| Measurand Mean | 45.7 |
| Measurand Min | |
| Measurand Max | |
| Measurand SD | 18.5 |